Component
Human vitamin D 25-hydroxylase / CYP2R1
Microsomal P450 that hydroxylates D2 and D3 at C25 and accepts reducing equivalents through POR.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Recombinant human CYP2R1 hydroxylated ergocalciferol at C25 to form 25-hydroxyvitamin D2.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary abstract, substrate product positions and kinetic comparison.
- experimental_model
- Recombinant human enzyme product identification
- exposure
- D2 substrate incubations; detailed concentration/time not available in abstract.
- limitations
- A shared enzyme does not by itself prove equal long-term serum responses to all D2 and D3 dosing regimens.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens protein
- plain_language
- The same first-step enzyme also activates D2.
- primary_references
- [shinkyo2004] Metabolism of vitamin D by human microsomal CYP2R1. (2004). https://pubmed.ncbi.nlm.nih.gov/15465040/ DOI: 10.1016/j.bbrc.2004.09.073
- tissue_or_cell_type
- microsomal enzyme preparation
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 302–315
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human enzyme product identification · source_derived_draft · unverified_draft
### vd-act-cyp2r1-d2 Recombinant human CYP2R1 hydroxylated ergocalciferol at C25 to form 25-hydroxyvitamin D2. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same first-step enzyme also activates D2. organism: Homo sapiens protein tissue_or_cell_type: microsomal enzyme preparation experimental_model: Recombinant human enzyme product identification limitations: A shared enzyme does not by itself prove equal long-term serum responses to all D2 and D3 dosing regimens. exposure: D2 substrate incubations; detailed concentration/time not available in abstract. cross_nutrient: false evidence_location: Primary abstract, substrate product positions and kinetic comparison. nutrient: Vitamin D2 and D3 [shinkyo2004] Metabolism of vitamin D by human microsomal CYP2R1. (2004). https://pubmed.ncbi.nlm.nih.gov/15465040/ DOI: 10.1016/j.bbrc.2004.09.073
Complete structured claim and evidenceRecombinant human CYP2R1 hydroxylated cholecalciferol at C25 to produce calcifediol.
Experimental context and source evidence
- cross_nutrient
- false
- evidence_location
- Primary abstract, substrate product positions and kinetic comparison.
- experimental_model
- Recombinant human enzyme metabolism
- exposure
- D3 substrate series; reported Km 0.45 micromolar and kcat 0.97 per minute.
- limitations
- In-vitro kinetics depend on assay setup and are not serum cutoffs.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens protein
- plain_language
- CYP2R1 performs the first activation step for D3.
- primary_references
- [shinkyo2004] Metabolism of vitamin D by human microsomal CYP2R1. (2004). https://pubmed.ncbi.nlm.nih.gov/15465040/ DOI: 10.1016/j.bbrc.2004.09.073
- tissue_or_cell_type
- microsomal enzyme preparation
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 287–300
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human enzyme metabolism · source_derived_draft · unverified_draft
### vd-act-cyp2r1-d3 Recombinant human CYP2R1 hydroxylated cholecalciferol at C25 to produce calcifediol. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP2R1 performs the first activation step for D3. organism: Homo sapiens protein tissue_or_cell_type: microsomal enzyme preparation experimental_model: Recombinant human enzyme metabolism limitations: In-vitro kinetics depend on assay setup and are not serum cutoffs. exposure: D3 substrate series; reported Km 0.45 micromolar and kcat 0.97 per minute. cross_nutrient: false evidence_location: Primary abstract, substrate product positions and kinetic comparison. nutrient: Vitamin D2 and D3 [shinkyo2004] Metabolism of vitamin D by human microsomal CYP2R1. (2004). https://pubmed.ncbi.nlm.nih.gov/15465040/ DOI: 10.1016/j.bbrc.2004.09.073
Complete structured claim and evidenceThe human CYP2R1-D3 structure contained heme, with the vitamin D3 side chain directed toward this catalytic prosthetic group.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Primary abstract and structure PDB 3C6G.
- experimental_model
- Purified human enzyme crystallography
- exposure
- CYP2R1-D3 crystal complex; PDB 3C6G.
- limitations
- A structural iron requirement is not evidence that iron supplements increase vitamin D activation in iron-replete people.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens protein
- plain_language
- D3 activation uses an iron-containing heme enzyme.
- primary_references
- [strushkevich2008] Structural analysis of CYP2R1 in complex with vitamin D3. (2008). https://pubmed.ncbi.nlm.nih.gov/18511070/ DOI: 10.1016/j.jmb.2008.03.065
- tissue_or_cell_type
- CYP2R1 active site
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 377–390
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified human enzyme crystallography · source_derived_draft · unverified_draft
### vd-act-cyp2r1-heme The human CYP2R1-D3 structure contained heme, with the vitamin D3 side chain directed toward this catalytic prosthetic group. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: D3 activation uses an iron-containing heme enzyme. organism: Homo sapiens protein tissue_or_cell_type: CYP2R1 active site experimental_model: Purified human enzyme crystallography limitations: A structural iron requirement is not evidence that iron supplements increase vitamin D activation in iron-replete people. exposure: CYP2R1-D3 crystal complex; PDB 3C6G. cross_nutrient: true evidence_location: Primary abstract and structure PDB 3C6G. nutrient: Vitamin D2 and D3 [strushkevich2008] Structural analysis of CYP2R1 in complex with vitamin D3. (2008). https://pubmed.ncbi.nlm.nih.gov/18511070/ DOI: 10.1016/j.jmb.2008.03.065
Complete structured claim and evidence
What acts on it
Human POR supported CYP2R1-mediated cholecalciferol 25-hydroxylation, with maximal measured activity near a 4:1 POR:CYP2R1 molar ratio.
Experimental context and source evidence
- cross_nutrient
- true
- evidence_location
- Primary Figure 2C; Methods 2.3 and reconstitution assays.
- experimental_model
- Purified enzyme and phospholipid-vesicle reconstitution
- exposure
- 0.25 micromolar CYP2R1; varied POR; 30 min at 37 C; Figure 2C.
- limitations
- Assay optimum is not a tissue expression target or a vitamin dosing requirement.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens proteins
- plain_language
- CYP2R1 needs an electron-supplying partner.
- primary_references
- [cheng2018] Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3. (2018). https://pubmed.ncbi.nlm.nih.gov/28716760/ DOI: 10.1016/j.jsbmb.2017.07.011
- tissue_or_cell_type
- reconstituted membrane
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 392–405
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified enzyme and phospholipid-vesicle reconstitution · source_derived_draft · unverified_draft
### vd-act-por-support Human POR supported CYP2R1-mediated cholecalciferol 25-hydroxylation, with maximal measured activity near a 4:1 POR:CYP2R1 molar ratio. Condition category: normal nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: CYP2R1 needs an electron-supplying partner. organism: Homo sapiens proteins tissue_or_cell_type: reconstituted membrane experimental_model: Purified enzyme and phospholipid-vesicle reconstitution limitations: Assay optimum is not a tissue expression target or a vitamin dosing requirement. exposure: 0.25 micromolar CYP2R1; varied POR; 30 min at 37 C; Figure 2C. cross_nutrient: true evidence_location: Primary Figure 2C; Methods 2.3 and reconstitution assays. nutrient: Vitamin D2 and D3 [cheng2018] Properties of purified CYP2R1 in a reconstituted membrane environment and its 25-hydroxylation of 20-hydroxyvitamin D3. (2018). https://pubmed.ncbi.nlm.nih.gov/28716760/ DOI: 10.1016/j.jsbmb.2017.07.011
Complete structured claim and evidence
Where it participates (unsigned role)
The patient-derived human CYP2R1 Leu99Pro variant lost detectable D3 25-hydroxylase activity in the expression assays.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- false
- evidence_location
- Results, Figures 3-5 and primary abstract.
- experimental_model
- Patient-derived allele expressed in cells
- exposure
- L99P versus wild-type CYP2R1; D3 biochemical/reporting assays.
- limitations
- The patient had residual circulating metabolites and responded to D2 treatment; this does not prove zero whole-body activation or zero residual D2 activity.
- nutrient
- Vitamin D2 and D3 · Vitamin D2 and D3
- nutrient_topic
- Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin D2 and D3
- organism
- Homo sapiens protein
- plain_language
- A CYP2R1 mutation can break the first D3 activation step.
- primary_references
- [cheng2004] Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. (2004). https://pubmed.ncbi.nlm.nih.gov/15128933/ DOI: 10.1073/pnas.0402490101
- tissue_or_cell_type
- heterologous expression model
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Vitamin D2 and D3: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 362–375
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Patient-derived allele expressed in cells · source_derived_draft · unverified_draft
### vd-act-cyp2r1-l99p The patient-derived human CYP2R1 Leu99Pro variant lost detectable D3 25-hydroxylase activity in the expression assays. Condition category: machinery_impairment nutrient_topic: Vitamin D2 and D3 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A CYP2R1 mutation can break the first D3 activation step. organism: Homo sapiens protein tissue_or_cell_type: heterologous expression model experimental_model: Patient-derived allele expressed in cells limitations: The patient had residual circulating metabolites and responded to D2 treatment; this does not prove zero whole-body activation or zero residual D2 activity. exposure: L99P versus wild-type CYP2R1; D3 biochemical/reporting assays. cross_nutrient: false evidence_location: Results, Figures 3-5 and primary abstract. nutrient: Vitamin D2 and D3 [cheng2004] Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. (2004). https://pubmed.ncbi.nlm.nih.gov/15128933/ DOI: 10.1073/pnas.0402490101
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.